top button
    Got Questions

Global IoT Summit 2018
Oct 31, 2018
The Leela Palace, Bangalore

    Connect to us
      Facebook Login
      Site Registration Why to Join

Facebook Login
Site Registration

Biopharmaceutical Fermentation Systems Market Share Insights Shared in Detailed Report

0 votes

Transparency Market Research (TMR) has published a new report titled ‘Biopharmaceutical Fermentation Systems Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026.’ According to the report, the global biopharmaceutical fermentation systems market was valued at US$ 10.0 Bn in 2017 and is projected to reach US$ 17.8 Bn by 2026, expanding at a CAGR of over 6.0% during the forecast period from 2018 to 2026. Biopharmaceuticals is an exponentially growing therapeutic segment, with several novel therapies in pipeline.

Microbial produced biopharmaceuticals generated revenue of around US$ 100 Bn in 2017 and the segment is estimated to expand at a significant CAGR. The global biopharmaceutical fermentation system market is driven by increased usage of fermentation derived products in various industries across the globe due to their natural structure, low cost, and better output. Moreover, rise in research and developmental activities in different fields of fermentation technology, technological advancements, rise in awareness about products, and launch of new products are the factors expected to drive the market in the near future.

Request PDF Sample of Biopharmaceutical Fermentation Systems Market Report @

Increase in geriatric population, rise in prevalence of chronic diseases across the world, and surge in health care expenditure propel demand for biopharmaceuticals. This in turn is likely to fuel the growth of the global biopharmaceutical fermentation systems market during the forecast period. Several pharmaceutical companies are engaged in research and development of innovative new formulations and biological drugs to meet the unmet therapeutic needs. For instance, Biocon, India’s largest, innovation-led, fully-integrated biopharmaceutical company which ranks among top three biosimilar global players for insulin, has commercialized the rh-insulin (recombinant human insulin) through Pichia fermentation technology. Rh Insulin and Insulin Glargine are registered in over 60 and 20 emerging markets, respectively.

The report offers detailed segmentation of the global biopharmaceutical fermentation systems market based on product type, application, and end-user. The market has also been segmented based on region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa). Development of new biotherapeutics with smaller molecular weight is expected to drive adoption of fermentation systems.

Usage of these systems for production of antibody fragments, antibody drug conjugate (ADCs) components, and small peptide fragments is likely to increase in the near future. Introduction of personalized medicines and varying product portfolio are likely to propel demand for more flexible and small to medium capacity production systems for fermentation. Instead of using large capacity fermenters, biopharmaceutical manufacturers can rely on small scale single use systems with capacity of 100 liters to 500 liters to produce these biotherapeutics.

Buy Now “Biopharmaceutical Fermentation Systems Market ” Research Report @

Downstream Process Products to Account for Major Share and Register Strong Growth

Technological advancements in bioproduction and development of genetically engineered microbial strains contributes to the high yield of microbial-based biopharmaceutical production. Stringent regulations and trend of continuous manufacturing & single use technology are poised to augment the downstream process products segment. In terms of application, the recombinant protein segment is expected to account for a leading share of the market by 2026. The segment is also likely to expand at a rapid pace during the forecast period.

Advancement in recombinant technologies such as gene translation in microbial systems is anticipated to drive the segment. Use of these systems in production of antibody drug conjugates (ADCs) is projected to propel the segment during the forecast period. Moreover, microbial systems have been widely used in the production of recombinant protein since the introduction of insulin produced using genetically engineered E.coli strains. Technological expertise, high production capacities, and large number of raw material suppliers have contributed to the leading share of the segment.

Asia Pacific to Register Exponential Growth and Create High Incremental Opportunity

Asia Pacific is expected to present significant opportunities in the biopharmaceutical fermentation systems market due to changing economic profiles, rapid urbanization, rise in health care spending and investment, and increase in incidence of chronic lifestyle diseases. However, in terms of revenue, North America was the leading market for biopharmaceutical fermentation systems in 2017. The market in North America is anticipated to witness moderate growth during the forecast period. Presence of key players, well-established health care infrastructure, increase in geriatric population, and rise in health care expenditure propel the market in the region.

Merck KGaA and Sartorius Stedim Biotech to Lead Market

The global biopharmaceutical fermentation systems market is highly fragmented, with top five players accounting for major share. GE Healthcare, Merck KGaA, Thermo Fisher Scientific, Sartorius Stedim Biotech, and Danaher Corporation are the five leading players operating in the market. Merck KGaA and Sartorius Stedim Biotech are likely to continue to hold significant market share during the forecast period.

The companies have strong presence in the fermenters segment. Merck KGaA is projected to witness strong growth in Asia Pacific during the forecast period, owing to increase in investments made by the company in infrastructure development and development of new products. Major companies profiled in this report are GE Healthcare, Thermo Fisher Scientific Inc., Danaher Corporation, Sartorius StedimBiotech, Merck KGaA, Eppendorf AG, F. Hoffmann-La Roche Ltd., Nova Biomedicals, Lonza, and Becton, Dickinson and Company.

More Trending Reports by Transparency Market Research –

Automated Sample Storage Market:

Menopausal Hot Flashes Market:

posted 4 days ago by Bella Watson

  Promote This Article
Facebook Share Button Twitter Share Button Google+ Share Button LinkedIn Share Button Multiple Social Share Button

Related Articles
0 votes

Transparency Market Research (TMR) has published a new report titled, “Bowel Management Systems Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”. According to the report, the global bowel management systems market was valued at US$ 1,682.95 Mn in 2017 and is projected to expand at a CAGR of 3.70% from 2018 to 2026. Increase in the prevalence of fecal incontinence and constipation in elderly population and rising geriatric population are anticipated to boost the global market from 2018 to 2026.

North America and Europe are expected to dominate the global bowel management systems market in the next few years, owing to new product launches, demand for technologically advanced bowel management systems in developed countries, and proactive population seeking physicians’ advice for bowel management. Key players operating in the global bowel management systems market strive to enter into distribution agreements and strategic acquisitions in order to strengthen their footprint across the world.

Systems segment to expand at prominent growth rate

The report offers detailed segmentation of the global bowel management systems market. Based on product, the market has been segmented into systems and accessories. The systems segment is expected to propel at a high growth rate owing to the rising demand for minimally invasive treatment options due to their effectiveness and cost-efficiency. The irrigation systems sub-segment holds a major share of the systems segment owing to the ease of use and effectiveness of the treatment. These help improve the quality of life, prevent infections, provide odor control, and reduce daily nursing time.

Request a Sample of Bowel Management Systems Market –

Adult segment to expand at rapid pace

The adult segment is likely to expand at a high CAGR during the forecast period, owing to increase in the geriatric population. Additionally, rising life expectancy, owing to the decline in the mortality rate, fuels the market. For instance, in the U.S., according to Population Reference Bureau Report, the geriatric population, over 65 years of age, is anticipated to reach more than 98 Mn by 2060, from 46 Mn in 2017. Moreover, increasing longevity among the geriatric population, which reached 79 years in 2013 from 68 years in 1950, would propel the market.

Hospitals segment held major share

In terms of end-user, the global bowel management systems market has been divided into hospitals, ambulatory surgical centers, and home-care settings. The hospitals segment held a major share of the market in 2017. Expansion of the segment can be attributed to the rising cases of spina bifida and anorectal malfunctions among the pediatric population and rise in the number of surgical procedures such as spinal cord injuries in adults.

Asia Pacific market to be driven by increase in geriatric population in Japan and India

In terms of revenue, Europe dominated the global bowel management systems market in 2017. The market in Asia Pacific is anticipated to expand at a rapid pace during the forecast period. Expansion of the bowel management systems market in the region is attributed to the increase in geriatric population and rise in the number of patients suffering from fecal incontinence and constipation. Additionally, new product launches, changing reimbursement scenario, rise in awareness among people, and improving healthcare infrastructure are major factors driving the market in Asia Pacific.

Buy Now “Bowel Management Systems Market ” Research Report @

Strategic acquisitions is the primary strategy adopted by market players

The report also provides profiles of leading players operating in the global bowel management systems market. Coloplast A/S, Medtronic plc, Hollister Incorporated and ConvaTec Group Plc. are major players in the market, offering products with proprietary technologies. Major market players adopted the strategy of inorganic growth in order to strengthen their market presence.

For instance, Coloplast acquired direct-to-consumer homecare companies globally, including IncoCare Gunhild Vieler GmbH in Germany, in 2018; SAS Lilial in France, in 2017; and Comfort Medical in the U.S., in 2016. Other players include Cogentix Medical, Inc. (acquired by LABORIE Medical Technologies), Consure Medical, ProSys International Ltd., Aquaflush Medical Limited, C. R. Bard, Inc. (acquired by Becton, Dickinson and Company), B. Braun Melsungen AG, Respiratory Technology Corporation, MBH International A/S, Wellspect Healthcare (Part of Dentsply Sirona Company), and Axonics Modulation Technologies.

0 votes

A recent report on the global human reproductive technologies market has been published by Transparency Market Research. The report, titled “Human Reproductive Technologies Market – Global Industry Analysis, Size, Procedures, Growth, Trends and Forecast, 2013 – 2019,” projects this market to expand at a CAGR of 2.20% during the period from 2013 to 2019. The market is estimated to stand at a valuation of US$27.1 bn by 2019.

According to the World Health Organization, in 2010, about 1.9% of the female population worldwide in the age group of 20-44 years was unable to conceive the first child. The growing prevalence of infertility has been attributed to a number of environmental and socio-economic factors. The various human reproductive technologies have witnessed increasing popularity in the past couple of years for the treatment of infertility among both men and women.

With the rise in female employment, there has been a growing trend of a delay in conception. Factors such as pollution, smoking, stress, and obesity have led to an increase in infertile population. The growing prevalence of unwanted pregnancies, initiatives taken by governments and NGOs to promote contraceptive products, and the implementation of favorable policies such as the Affordable Care Act has propelled the growth of the global human reproductive technologies market.

Get Sample with Latest Research @

However, limited insurance coverage and the side effects of contraceptive drugs and devices might hamper the growth of the market during the forecast period. The global human reproductive technologies market has a significant opportunity to grow with the rise in medical tourism, government support for the treatment of infertility, and the presence of a strong pipeline of contraceptive drugs.

The market for contraceptives stood at a valuation of US$16 bn in 2012. During the forecast period, the market is estimated to expand at a CAGR of 5.5%. In 2012, the oral contraceptives segment witnessed the highest demand due to the availability of contraceptives as an over-the-counter drug.

The key regions in the global human reproductive technologies market are Europe, Asia Pacific, North America, and Rest of the World. In 2012, North America emerged as the leading region in the market, followed by Europe. North America is predicted to dominate the market throughout the forecast period. However, the market is projected to register the fastest growth in Asia Pacific due to the increasing awareness about contraceptives, high population density, and rise in disposable income.

Some of the major players in the global human reproductive technologies market are Bayer AG, Abbott Laboratories, Actavis Inc., Boston Scientific Corporation, Church & Dwight Co. Inc., Merck KGaA, Warner Chilcott plc, Reckitt Benckiser Group plc, Merck Serono, Pfizer Inc., Johnson & Johnson, Cook Medical Inc., and Teva Pharmaceutical Industries Ltd. The report discusses some of the key attributes of the market players including their business strategies, product portfolio, and recent developments. Through a SWOT analysis, the report identifies the future growth opportunities for the market vendors.

More Trending Reports by Transparency Market Research –

Helicobacter Pylori (H. Pylori) Non-invasive Testing Market:

Brain Computer Interface Market:—tmr-682767451.html

0 votes

With a number of established players, the global blood flow measurement devices market is demonstrating a highly competitive landscape, states a new research report by Transparency Market Research (TMR). Transonic Systems Inc., Perimed AB, Moor Instruments Ltd., Medistim ASA, GF Health Products Inc., Deltex Medical, Cook Medical Inc., Compumedics Ltd., Atys Medical., and ArjoHuntleigh Inc. are some of the key vendors of blood flow measurement devices across the world. The focus of these players is predominantly on strengthening their position in the global market and for that they are increasingly involving into strategic alliances and mergers and acquisitions. The number of players in this market is also projected to surge in the near future, giving rise to the competition, states the research study.

According to the research report, the global market for blood flow measurement devices stood at US$0.27 bn in 2012. Progressing at a CAGR of 8.70% during the period from 2013 to 2019, the market’s opportunity is anticipated to reach US$0.50 bn by the end of the forecast period. Ultrasonic doppler flowmeters, laser doppler flowmeters, and electromagnetic flowmeters are the main products available in this market. Among these, the demand for ultrasonic doppler flowmeters have been relatively higher and this trend is anticipated to remain so over the next few years, notes the market study.

Get Sample with Latest Research @

Increasing Awareness Regarding Health and Fitness to Ensure North America’s Dominance

In terms of the geography, North America has been leading the worldwide market for blood flow measurement devices, thanks to the high awareness level pertaining to health and fitness among consumers. Going forward, this regional market is likely to remain on the top in the years to come on account of the rising prevalence of circulatory diseases, such as peripheral vascular diseases. Among other regional markets, Europe and Asia Pacific are expected to register significant growth over the next few years due to the increasing acceptance of minimally invasive devices and the considerable rise in the disposable income, enabling consumers to spend on expensive treatments, reports the research study.

High Prevalence of Peripheral Vascular Disorders to Boost Market

The global market for blood flow measurement devices has been witnessing a significant rise in its valuation and is expected to remain observing high growth in the near future, thanks to the augmenting demand for these device, owing to the high prevalence of peripheral vascular disorders among people across the world. These devices find extensive application in the diagnosis of diabetic complications, arterial occlusions, and intracranial monitoring in stroke and brain injury. The increasing base of geriatrics population, extremely susceptible to a wide array of diseases, is also projected to support the growth of this market, considerably, states the research report.

More Trending Reports by Transparency Market Research –

Hearing Aids Market:

Diabetes Drugs Market:

0 votes

Transparency Market Research (TMR) anticipates that the particle therapy market features fragmented vendor landscape owing to a large number of key players operating in the market. Varian Medical Systems, Inc., IBA Worldwide, Hitachi, Ltd., and Sumitomo Heavy Industries, Ltd are some of the key players in the global particle therapy market.

According to TMR, the market stood at a value of US$ 364.8 Mn in 2017 and is projected to expand at a CAGR of 8.0% from 2018 to 2026. At this rate, the market is estimated to reach at a valuation of US$727.0 mn by 2026-end.

On the geographical standpoint, North America and Europe are projected to dominate the global particle therapy market, attributable to an expansion in the interest for proficient and powerful administration of particle therapy and high rate of reception of particle therapy for treatment arranging by oncologist.

The market in Asia Pacific is anticipated to extend at an exponential development rate during the conjecture time frame. This is ascribed to an enormous base of claim to fame facilities and medical clinics, ascend in the geriatric populace with cerebrum and spine tumor sicknesses requiring particle therapy administrations, and increment in the rate of appropriation of new treatments, for example, carbon and particle therapy for the treatment of malignant growth patients. The market for particle therapy in Latin America is probably going to extend at a moderate development rate during the figure time frame.

Get Sample with Latest Research @

Improving Quality of Particle Therapy Drives the Market Growth

The global particle therapy market is anticipated to be possibly determined by the highlights and qualities of particle therapy. Particle therapy is being offered by different particle therapy delivering organizations so as to streamline everyday work process and increment the income of the practices. Particle therapy gives differing highlights and advantages, going from patient agony behaving solutions for treatment methodology. These highlights help doctors and medical attendants to streamline the tumor treatment therapy action required for patients so as to keep up their day by day work process productively and adequately.

The key players offering the particle therapy are presenting worth included highlights, for example, set up labs with administrations, for example, cyclotrons, synchrotrons, powerful methodology highlights, alongside imaging modules, accordingly decreasing the general working expense and subsequently, improving the general adequacy and proficiency of particle therapy rehearses.

Organizations are concentrating on the advancement of joined particle and carbon therapy offices in their framework so as to adequately coordinate the therapy or treatment technique and patient instruction and mindfulness programs on particle therapy. These worth included highlights spare the operational time of doctors and help improve its agony the executives execution among malignancy patients. 

Buy Now Particle Therapy Market Research Report @

Cyclotrons in anticipated to be very worthwhile portion for administrations

Cyclotrons are non-reactor sources that are utilized to create different radioisotopes or electrons or particles. High vitality utilization and breaking down apparatus produce half-life radioisotopes or particles that are used in the treatment of various kinds of malignant growth. Cyclotrons empower the client to practice low recurrence clinical applications, along these lines permitting the mending of outrageous instances of tumor deterioration, which thusly is probably going to move the section during the estimate time frame.

The act of atomic drug in Middle East and Asia has been growing essentially over the most recent couple of years. For example, most cyclotrons introduced in India are somewhere in the range of 12 and 18 MeV and just few of 30 MeV; nearly most cyclotrons introduced in Japan are somewhere in the range of 12 and 18 MeV just as 30 MeV.

0 votes

The global healthcare natural language processing (NLP) market is peculiar in itself, majorly due to the complex nature of its offerings. A report by Transparency Market Research (TMR) finds that the global market for healthcare natural language processing encapsulates a consolidated competitive landscape with a handful of strong market players. These leading market players have attained deftness with technology and execution of new plans, and this has been the prime reason behind their unchallenged position in the global healthcare NLP market.

It is expected that the handful of market players in the global market for healthcare natural language processing would continually invest in research and development of better algorithms for analyzing human languages. This would create hurdles for the entities that are planning to venture into the global healthcare NLP market. The new entrants who come into the market would face several obstacles due to the high standards set by the existential market vendors.

Transparency Market Research (TMR) finds that the global market for healthcare natural language processing (NLP) would expand at a starry CAGR of 18.805 from 2016 to 2024. Furthermore, the global market is projected to accumulate revenues worth US$4.3 bn by the end of 2024, rising up from a value of US$936 mn in 2015.

Request PDF Sample of Healthcare Natural Language Processing (NLP) Market Report @

Machine Learning Applications in Clinical Decision Making to Drive Demand

The ability of artificial intelligence and computer sciences to interpret natural human languages has largely benefitted the healthcare industry. The use of deep learning and analytic tools to interpret medical data and improve clinical decision making has given an impetus to the growth of the global healthcare NLP market. Furthermore, the engagement of patients in the treatment process has also increased with the deployment of natural language processing within healthcare. Hence, it is safe to estimate that the demand within the global healthcare NLP market would increase alongside the rising use of clinical informatics in healthcare.

Predictive analysis is another domain within healthcare that has taken a solid shape due to the emergence of natural language processing (NLP) in healthcare. Electronic health records (EHR) also hold importance for the healthcare industry, and it is easier to organize these records through the use of NLP. Hence, there are several factors that are expected to support the growth of the global market for healthcare natural language processing in the coming years.

Stuck In A Neck-To-Neck Competition With Other Brands? Buy Now “Healthcare Natural Language Processing (NLP) Market” Research Report @

Risk of Medical Errors to Hamper Growth

The vast number of medical concepts that need to be dealt with while deploying natural language processing in healthcare is a huge challenge to market growth. Even a slight error in processing of clinical data can have severe consequences for the healthcare industry. This is one of the major reasons behind the steady adoption of natural language processing within healthcare. Nevertheless, the rapidly advancing healthcare industry is expected to find pragmatic solutions to deal with the problem of vastly unorganized medical data.